Patents Represented by Attorney, Agent or Law Firm J. Timothy Meigs
  • Patent number: 6069301
    Abstract: Antibodies, monoclonal antibodies or fragments thereof which bind to brush border membrane vesicles of insect gut and the gene or genes which encode these proteins are provided. The monoclonal antibodies bind the gut of a target insect but do not bind to mammalian brush border membranes or to plant microsomes. The antibodies and the genes encoding them find use in constructing hybrid toxins for control of insect pests.
    Type: Grant
    Filed: December 20, 1996
    Date of Patent: May 30, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Nadine Barbara Carozzi, Michael Gene Koziel
  • Patent number: 6066783
    Abstract: The present invention is drawn to pesticidal strains and proteins. Bacillus strains which are capable of producing pesticidal proteins and auxiliary proteins during vegetative growth are provided. Also provided are the purified proteins, nucleotide sequences encoding the proteins and methods for using the strains, proteins and genes for controlling pests.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: May 23, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Gregory W. Warren, Michael G. Koziel, Martha A. Mullins, Gordon J. Nye, Brian Carr, Nalini M. Desai, Kristy Kostichka
  • Patent number: 6057490
    Abstract: Methods are provided for selecting parental plants exhibiting disease resistance and for using these plants in breeding programs. In one method of the invention, constitutive immunity (cim) mutants are screened for either resistance to a pathogen of interest or for the expression of systemic acquired resistance (SAR) genes. Such mutants having the desired traits or expressing the desired genes are then used in breeding programs. Parent plants can also be selected based on the constitutive expression of SAR genes. These mutants are phenotypically normal yet exhibit a significant level of disease resistance. Also disclosed are lesion-simulating-disease (lsd) mutants having a lesion mimic phenotype that also express SAR genes and exhibit disease resistance. Further disclosed are non-inducible immunity (nim) mutants that do not express SAR genes, even when induced by a pathogen. Methods of use for these mutants are also disclosed.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: May 2, 2000
    Assignee: Novartis Finance Corporation
    Inventors: John Andrew Ryals, Scott Joseph Uknes, Eric Russell Ward, Klaus Maleck
  • Patent number: 6051760
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: April 18, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 6040504
    Abstract: A promoter isolated from a cotton gene encoding the small subunit of ribulose bisphosphate carboxylase is described. The isolated promoter is operably linked to a coding sequence of interest to make a chimeric gene.
    Type: Grant
    Filed: February 10, 1998
    Date of Patent: March 21, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Douglas Rice, Nadine Carozzi, David M. Anderson, Kanniah Rajasekaran, Thirumale S. Rangan, Richard Yenofsky, Richard Lotstein
  • Patent number: 6031153
    Abstract: The present invention concerns a method of protecting plants from pathogen attack through synergistic disease resistance attained by applying a conventional microbicide to immunomodulated plants. Immunomodulated plants are those in which SAR is activated and are therefore referred to as "SAR-on" plants. Immunomodulated plants may be provided in at least three different ways: by applying to plants a chemical inducer of SAR such as BTH, INA, or SA; through a selective breeding program based on constitutive expression of SAR genes and/or a disease-resistant phenotype; or by transforming plants with one or more SAR genes such as a functional form of the NIM1 gene. By concurrently applying a microbicide to an immunomodulated plant, disease resistance is unexpectedly synergistically enhanced; i.e., the level of disease resistance is greater than the expected additive levels of disease resistance.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: February 29, 2000
    Assignee: Novartis AG
    Inventors: John Andrew Ryals, Leslie Bethards Friedrich, Scott Joseph Uknes, Antonio Molina-Fernandez, Wilhelm Ruess, Gertrude Knauf-Beiter, Ruth Beatrice Kung, Helmut Kessmann, Michael Oostendorp
  • Patent number: 6023012
    Abstract: The present invention provides novel DNA sequences isolated from soybean, wheat, cotton, sugar beet, rape, rice, sorghum, and sugar cane that coding for enzymes having protoporphyrinogen oxidase (protox) activity. In addition, the present invention teaches modified forms of protox enzymes that are herbicide tolerant. Plants expressing herbicide tolerant protox enzymes taught herein are also provided. These plants may be engineered for resistance to protox inhibitors via mutation of the native protox gene to a resistant form or they may be transformed with a gene encoding an inhibitor-resistant from of a plant protox enzyme.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: February 8, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Sandra L. Volrath, Marie A. Johnson, Sharon L. Potter, Eric R. Ward, Peter B. Heifetz
  • Patent number: 6018104
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 25, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Vance C. Kramer, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 6018099
    Abstract: DNA sequences are able to function as promoters of tissue-preferential transcription of associated DNA sequences in plants, particularly in the roots. These DNA sequences can be used in transformation vectors to produce transgenic plants which will express the heterologous genes preferentially in tissue, particularly in the roots of maize plants.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: January 25, 2000
    Assignee: Novartis Finance Corporation
    Inventor: Annick J. de Framond
  • Patent number: 6018105
    Abstract: Promoters naturally associated with plant protoporphyrinogen oxidase (protox) coding sequences, and derivatives thereof, are provided. These promoters can be used to control the expression of an operably linked heterologous coding sequence in a plant cell. These promoters are particularly useful for expressing modified forms of herbicide target enzymes, particularly modified forms of protox, to achieve tolerance to herbicides that inhibit the corresponding unmodified enzymes. Recombinant DNA molecules and chimeric genes comprising these promoters are provided, as well as plant tissue and plants containing such chimeric genes.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: January 25, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Marie A. Johnson, Sandra L. Volrath, Eric R. Ward
  • Patent number: 6006470
    Abstract: The use of mannose binding lectins derived from Amaryllidaceae, Alliaceae, or Vicieae for the control of nematodes, in which said use may be either direct or via transgenic plant expression, and a method therefor.
    Type: Grant
    Filed: September 30, 1996
    Date of Patent: December 28, 1999
    Assignee: Novartis AG
    Inventors: Irene Geoghegan, Walter Robertson, Nicholas Birch, Angharad Margaret Roscoe Gatehouse
  • Patent number: 6002068
    Abstract: The present invention relates, in general, to methods and compositions for controlling insects in monocotyledonous plants (monocots), particularly maize. More precisely, the present invention relates to (1) a method for controlling insects comprising feeding or contacting an insect with an insecticidal amount of transgenic monocotyledonous plant cells comprising a recombinant DNA sequence comprising a coding sequence encoding peroxidase and (2) a fertile transgenic monocot plant comprising a recombinant DNA sequence comprising a coding sequence encoding peroxidase.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: December 14, 1999
    Assignees: Novartis Finance Corporation, The Ohio State University, The United States of America as represented by the Secretary of Agriculture
    Inventors: Laura Privalle, Juan Estruch, Martha Wright, Martha Beale Hill, Patrick Francis Dowd, Lawrence Mark Lagrimini
  • Patent number: 5986082
    Abstract: The NIM1 gene product is a structural homologue of the mammalian signal transduction factor I.kappa.B subclass .alpha.. The present invention exploits this discovery to provide altered forms of NIM1 that act as dominant-negative regulators of the systemic acquired resistance (SAR) signal transduction pathway. These altered forms of NIM1 confer the opposite phenotype as the nim1 mutant in plants transformed with the altered forms of NIM1; i.e., the transgenic plants exhibit constitutive SAR gene expression and a constitutive immunity (CIM) phenotype. The present invention further concerns DNA molecules encoding altered forms of the NIM1 gene, expression vectors containing such DNA molecules, and plants and plant cells transformed therewith. The invention also concerns methods of activating SAR in plants and conferring to plants a CIM phenotype and broad spectrum disease resistance by transforming the plants with DNA molecules encoding altered forms of the NIM1 gene product.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: November 16, 1999
    Assignee: Novartis AG
    Inventors: Scott Joseph Uknes, Michelle Denise Hunt, Henry-York Steiner, John Andrew Ryals
  • Patent number: 5955348
    Abstract: Strains of Pseudomonas have been genetically engineered to have enhanced biocontrol properties. The strains of the invention are particularly effective against plant pathogenic fungi such as species of Rhizoctonia and Pythium, because the strains produce enhanced amounts of antifungal metabolites such as pyrrolnitrin that are active against these fungal pathogens. Both the genetically modified biocontrol strains and the antifungal metabolites can be used as active agents for biocontrol compositions.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: September 21, 1999
    Assignee: Novartis AG
    Inventors: James Madison Ligon, Nancy R. Torkewitz, Dwight Steven Hill, Thomas Deane Gaffney, Jill Michelle Stafford
  • Patent number: 5955274
    Abstract: DNA sequences from the Internal Transcribed Spacers of the ribosomal RNA gene region are described for different species and strains of Septoria, Pseudocercosporella, Fusarium and Mycosphaerella. Specific primers from within these sequences are identified as being useful for the identification of the fungal isolates using PCR-based techniques.
    Type: Grant
    Filed: October 15, 1996
    Date of Patent: September 21, 1999
    Assignee: Novartis Finance Corporation
    Inventors: James M. Ligon, James J. Beck
  • Patent number: 5942662
    Abstract: The present invention provides chemically regulatable DNA sequences capable of regulating transcription of an associated DNA sequence in plants or plant tissues, chimeric constructions containing such sequences, vectors containing such sequences and chimeric constructions, and transgenic plants and plant tissues containing these chimeric constructions. In one aspect, the chemically regulatable DNA sequences of the invention are derived from the 5' region of genes encoding pathogenisis-related (PR) proteins. The present invention also provides anti-pathogenic sequences derived from novel cDNAs coding for PR proteins which can be genetically engineered and transformed into plants to confer enhanced resistance to disease.
    Type: Grant
    Filed: November 14, 1997
    Date of Patent: August 24, 1999
    Assignee: Novartis Finance Corporation
    Inventors: John A. Ryals, Christian T. Harms, Leslie B. Friedrich, James J. Beck, Scott J. Uknes, Eric R. Ward
  • Patent number: 5939602
    Abstract: The present invention provides novel DNA sequences coding for plant protoporphyrinogen oxidase (protox) enzymes from soybean, wheat, cotton, sugar beet, rape, rice and sorghum. In addition, the present invention teaches modified forms of protox enzymes that are herbicide tolerant. Plants expressing herbicide tolerant protox enzymes taught herein are also provided. These plants may be engineered for resistance to protox inhibitors via mutation of the native protox gene to a resistant form or they may be transformed with a gene encoding an inhibitor-resistant from of a plant protox enzyme.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: August 17, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Sandra L. Volrath, Marie A. Johnson, Eric R. Ward, Peter B. Heifetz
  • Patent number: PP11192
    Abstract: A new and distinct variety of Verbena plant, named Mylena, characterized particularly as to novelty by large, early appearing, dark purple flowers, and a growth habit that is initially semi-erect but later spreading and hanging.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: January 25, 2000
    Assignee: Novartis AG
    Inventor: Henricus G. W. Stemkens
  • Patent number: PP11197
    Abstract: A new and distinct variety of Verbena plant, named Silvena, characterized particularly as to novelty by large, early-appearing purple flowers, and a growth habit that is initially semi-erect but later spreading and hanging.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: February 1, 2000
    Assignee: Novartis AG
    Inventor: Henricus G. W. Stemkens
  • Patent number: PP11231
    Abstract: A new and distinct variety of Verbena plant, named Morena, characterized particularly as to novelty by large, early-appearing, vivid pink flowers, and a growth habit that is initially semi-erect but later spreading and hanging.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: February 22, 2000
    Assignee: Novartis AG
    Inventor: Henricus G. W. Stemkens